Apart from iron supplements, recombinant erythropoietin (Epo) is also used for the treatment of IBD‐associated anemia,[18] whereas side effects such as the increased risk of thromboembolic events, stroke, or cardiovascular disorders were observed in some patients. The gene discussed is EPO; the disease is cardiovascular disorder.